Several previous studies have noted that G3BPs (G3BP1 and G3BP2) are upregulated and associated with poor prognosis in human cancers including gastric [16], breast [17, 19], lung cancer [20], sarcoma [21], prostate [22], hepatic [48], and colon cancer [73]. Here, G3BP2 is linked to sarcoma.